Ebola Treatment Shown to Work on Infected Monkeys

Global Security Newswire Staff
Add to Briefcase
See more stories about...
Global Security Newswire Staff
Aug. 22, 2013, 9:02 a.m.

A new Ebola drug grown from spe­cial to­bacco plants has been shown to cure mon­keys that were already dis­play­ing signs of in­fec­tion by the vir­al hem­or­rhagic fever, the Los Angeles Times re­por­ted on Wed­nes­day.

Oth­er Ebola coun­ter­meas­ures have been shown to work on in­fec­ted an­im­als be­fore they start dis­play­ing symp­toms of the highly vir­u­lent and leth­al dis­ease. However, this is the first time a drug has demon­strated any ef­fect­ive­ness after signs of the vir­us have mani­fes­ted. That is re­garded as a cru­cial cap­ab­il­ity in the event of a real-life dis­ease epi­dem­ic, ac­cord­ing to vir­o­lo­gist Gene Olinger, who works at the Army Med­ic­al Re­search In­sti­tute of In­fec­tious Dis­eases at Fort De­t­rick, Md.

“We’ve pushed the op­por­tun­ity to treat people to the point where they walk in and say, ‘I have a fever,’” said Olinger, co-au­thor of a re­port on the new Ebola drug pub­lished by the Sci­ence Trans­la­tion­al Medi­cine journ­al on Wed­nes­day. “A lot of folks in the field would have thought pro­tect­ing an an­im­al at the time of fever and viremia is too late to have a clin­ic­al be­ne­fit.”

Ebola is one of the most deadly and con­ta­gious dis­eases known to ex­ist in nature. The lack of ad­equate vac­cines and an­ti­dotes for the dis­ease have made it a ser­i­ous worry for biode­fense spe­cial­ists con­cerned about its pos­sible ap­plic­a­tions as a bio­lo­gic­al weapon.

In the re­cent study, sev­en in­fec­ted rhesus mon­keys were ad­min­istered the ex­per­i­ment­al treat­ment MB-003 through their veins once every three days. Three of the mon­keys did not die, res­ult­ing in a stat­ist­ic­ally not­able suc­cess rate of 43 per­cent.

Fort De­t­rick sci­ent­ist and lead study au­thor James Pet­titt said it is prob­able that in a real-life out­break, the drug would be ad­min­istered at a high­er dosage and with great­er fre­quency.

“We think we’ll get bet­ter res­ults,” the re­search­er said.

Grow­ing the drug from spe­cially de­veloped to­bacco leaves is not only less costly than con­ven­tion­al cell-based meth­ods, but also al­lows for large batches of the drug to be pro­duced on fairly short, weeklong sched­ules, ac­cord­ing to the Times art­icle.

Olinger said fur­ther meas­ures will be taken to im­prove MB-003 by adding to it more Ebola an­ti­bod­ies that were dis­covered by a dif­fer­ent group of re­search­ers.

What We're Following See More »
TRUMP CONTINUES TO LAWYER UP
Kasowitz Out, John Dowd In
1 days ago
THE LATEST

As the Russia investigation heats up, "the role of Marc E. Kasowitz, the president’s longtime New York lawyer, will be significantly reduced. Mr. Trump liked Mr. Kasowitz’s blunt, aggressive style, but he was not a natural fit in the delicate, politically charged criminal investigation. The veteran Washington defense lawyer John Dowd will take the lead in representing Mr. Trump for the Russia inquiry."

Source:
ALSO INQUIRES ABOUT PARDON POWER
Trump Looking to Discredit Mueller
1 days ago
THE LATEST

President Trump's attorneys are "actively compiling a list of Mueller’s alleged potential conflicts of interest, which they say could serve as a way to stymie his work." They plan to argued that Mueller is going outside the scope of his investigation, in inquiring into Trump's finances. They're also playing small ball, highlighting "donations to Democrats by some of" Mueller's team, and "an allegation that Mueller and Trump National Golf Club in Northern Virginia had a dispute over membership fees when Mueller resigned as a member in 2011." Trump is said to be incensed that Mueller may see his tax returns, and has been asking about his power to pardon his family members.

Source:
INCLUDES NY PROBE INTO MANAFORT
Why Yes, Mueller Is Looking into Trump Businesses
1 days ago
THE LATEST

In addition to ties between Russia and the Trump campaign, Robert Mueller's team is also "examining a broad range of transactions involving Trump’s businesses as well as those of his associates, according to a person familiar with the probe. FBI investigators and others are looking at Russian purchases of apartments in Trump buildings, Trump’s involvement in a controversial SoHo development in New York with Russian associates, the 2013 Miss Universe pageant in Moscow, and Trump’s sale of a Florida mansion to a Russian oligarch in 2008, the person said. The investigation also has absorbed a money-laundering probe begun by federal prosecutors in New York into Trump’s former campaign chairman Paul Manafort."

Source:
Mueller Expands Probe to Trump Business Transactions
2 days ago
THE DETAILS

Special Counsel Robert Mueller's team is "is examining a broad range of transactions involving Trump’s businesses as well as those of his associates", including "Russian purchases of apartments in Trump buildings, Trump’s involvement in a controversial SoHo development with Russian associates, the 2013 Miss Universe pageant in Moscow and Trump’s sale of a Florida mansion to a Russian oligarch in 2008."

Source:
ANALYSIS FROM CBO
32 Million More Uninsured by 2026 if Obamacare Repealed
2 days ago
THE LATEST

"A Senate bill to gut Obamacare would increase the number of uninsured people by 32 million and double premiums on Obamacare's exchanges by 2026, according to an analysis from the nonpartisan Congressional Budget Office. The analysis is of a bill that passed Congress in 2015 that would repeal Obamacare's taxes and some of the mandates. Republicans intend to leave Obamacare in place for two years while a replacement is crafted and implemented."

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login